Literature DB >> 6671798

Colonization pattern of the digestive tract by potentially pathogenic microorganisms: colonization-controlling mechanisms and consequences for antibiotic treatment.

D van der Waaij.   

Abstract

An outline is given of the various host-related and flora-related parts of the colonization resistance of the digestive tract. The host-related part of the colonization resistance has been found to be somewhat decreased by sublethal irradiation and leukemia (or chemotherapy), while treatment with antibiotics active against gram-positive flora may severely decrease the colonization resistance (depending on the antibiotic concentration established within the digestive tract during antibiotic therapy). The flora-related part of the colonization resistance, which controls colonization by potentially pathogenic microorganisms, differs greatly from one individual to the next. This observation appears to be important for the host-related part of the colonization resistance. Finally, it is concluded that in the clinical situation preference should be given to antibiotics which do not affect the part of the flora constituting colonization resistance for two reasons: 1) to limit the spread of (multi-) resistant potentially pathogenic microorganisms and 2) for infection prophylaxis in immunocompromised patients. In the latter situation, the potentially pathogenic microorganisms in the flora are selectively eliminated from the digestive tract, provided the antimicrobial drugs used for selective decontamination are active against the endogenous potentially pathogenic microorganisms and given in sufficient (oral) doses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6671798     DOI: 10.1007/bf01645295

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Determination of the colonization resistance of the digestive tract of individual mice.

Authors:  D van der Waaij; J M Berghuis
Journal:  J Hyg (Lond)       Date:  1974-06

2.  Fate of ingested Escherichia coli in normal persons.

Authors:  E M Cooke; I G Hettiaratchy; A C Buck
Journal:  J Med Microbiol       Date:  1972-08       Impact factor: 2.472

3.  Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora.

Authors:  K Sprunt; W Redman
Journal:  Ann Intern Med       Date:  1968-03       Impact factor: 25.391

4.  [Prevention of infection during induction therapy in acute leukemia].

Authors:  E Kurrle
Journal:  Klin Wochenschr       Date:  1981-10-01

Review 5.  The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics.

Authors:  D van der Waaij
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

6.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

7.  Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1974-04

8.  Colonization resistance of the digestive tract: clinical consequences and implications.

Authors:  D van der Waaij
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

9.  Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1972-06

10.  Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.

Authors:  A W Dekker; M Rozenberg-Arska; J J Sixma; J Verhoef
Journal:  Ann Intern Med       Date:  1981-11       Impact factor: 25.391

View more
  8 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

Review 2.  A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.

Authors:  C Edlund; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

3.  Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation.

Authors:  T Schmeiser; E Kurrle; R Arnold; D Krieger; W Heit; H Heimpel
Journal:  Infection       Date:  1988       Impact factor: 3.553

4.  Infections after experimental cadaver bone marrow transplantation in beagle dogs. Transplantations with and without selective gastrointestinal decontamination.

Authors:  E Haralambie; A Schmidt-Weinmar
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection.

Authors: 
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

Review 6.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

7.  Comparison of antagonistic ability against enteropathogens by G+ and G- anaerobic dominant components of human fecal microbiota.

Authors:  D A Gomes; A M L Souza; R V Lopes; A C Nunes; J R Nicoli
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

8.  Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria.

Authors:  Bärbel Stecher; Samuel Chaffron; Rina Käppeli; Siegfried Hapfelmeier; Susanne Freedrich; Thomas C Weber; Jorum Kirundi; Mrutyunjay Suar; Kathy D McCoy; Christian von Mering; Andrew J Macpherson; Wolf-Dietrich Hardt
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.